MedPath

Cerebral Microembolism in the Critically Ill With Acute Kidney Injury

Not Applicable
Terminated
Conditions
Cerebral Embolism
Interventions
Device: Renal replacement therapy
Registration Number
NCT02621749
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

The primary objective of this study is to investigate the impact of continuous renal replacement therapy and intermittent renal replacement therapy on microbubble / cerebral microemboli generation in a cohort of critically ill patients with dialysis-dependent acute kidney injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • > 18 yrs.
  • Signed IC
Exclusion Criteria
  • Heart disease (PFO, ASD, VSD, severe valvular disease)
  • Atrial fibrillation
  • Cerebrovascular pathology
  • Missing temporal bone window
  • Allergy to plastic contained in the investigative device (transcranial Doppler)
  • Chronic kidney disease
  • Pregnancy
  • Participation in another study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IRRT groupRenal replacement therapythe IRRT group receives intermittent renal replacement therapy after termination of CRRT.
CRRT groupRenal replacement therapythe CRRT group receives continuous renal replacement therapy for acute kidney injury
Primary Outcome Measures
NameTimeMethod
Cerebral Microembolic Load detected by Transcranial Doppler UltrasoundDuring hemodialysis therapy
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath